RBM15 and nonpapillary renal cell carcinoma: In summary, RBM15 promotes ccRCC progression through epigenetic activation and m6A-dependent stabilization of oncogenic transcripts, while resveratrol emerges as a promising RBM15-targeted therapeutic approach.